-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $4

Benzinga·05/14/2026 18:57:41
Listen to the news
Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $3.5 to $4.